Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2005; 11(42): 6701-6706
Published online Nov 14, 2005. doi: 10.3748/wjg.v11.i42.6701
Figure 1
Figure 1 Electrophoresis of RT-PCR products amplified from the total RNA preparations of the tumor (T) and non-tumor liver (NT) tissues from HCC patients. For both tumor and non-tumor total RNA preparations, the RT-PCR products corresponding to ST6Gal I and β-Actin DNA showing the expected sizes (421 bp and 305 bp respectively) were obtained. Commercially available human normal liver cDNA was used as the positive control. Similar DIG-labeled RT-PCR products with the same sizes were obtained when DIG-dNTPs were used.
Figure 2
Figure 2 The frequency of poorly differentiated tumors among the 19 HCC patients with different relative tumor ST6Gal I activity or with different preoperative serum msAFP percentage. Differences between the study groups were tested by Fisher’s exact test. 1P = 0.045.
Figure 3
Figure 3 Survival curves of 19 patients with operable hepatocellular carcinoma after surgical resection according to relative tumor ST6Gal I activity (A) and preoperative serum msAFP percentage (B). Censored cases (O).